Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
All animal experiments performed in this study were approved by the relevant ethics committees, and all experimental procedures comply with local laws and ethical standards
2 Review of gut microbiota and asthma 2.1 Gut microbiota and asthma The etiology of asthma remains incompletely understood
However, it is unclear how much diet-induced changes in microbiota contributes to the effects on the brain per se [224]
KEY FINDINGS Average weight loss on treatment: 7.9 kg (all GLP-1s) 16.1 kg (newer GLP-1s like semaglutide/tirzepatide) Weight regained after stopping: 0.70.8 kg/month 8.39.6 kg regained in the first year Full return to baseline: 0.9 years (older GLP-1s) 1.7 years (newer GLP-1s) Bottom line: GLP-1s are effective, but without ongoing treatment or structured long-term care, the benefits fade quickly
Pounding head, twisting stomach, no chance of being a person before noon
To view or add a comment, sign in ERA2026 l HighTide Therapeutics Presents New Findings Supporting HTD1801's Renoprotective Potential in Oral Presentation Targeting the AMPK-NLRP3 axis, HTD1801 continues to show promising renoprotective potential in CKD and other renal diseases
US$ 24.13
US$ 27.55
US$ 28.16
US$ 23.38
US$ 25.56
US$ 20.97
